[Early detection of familial hypercholesterolemia: The Vroni study]
- PMID: 40113704
- DOI: 10.1007/s15006-025-4744-7
[Early detection of familial hypercholesterolemia: The Vroni study]
Abstract
Familial Hypercholesterolemia (FH), affecting 1 in 150-250 people, poses a significant cardiovascular risk. In the German Vroni Study, children aged 5-14 successfully screens for FH, combining LDL-C measurement with genetic testing. Early intervention reduces cardiovascular risks to general population levels. Over 28,000 children have been screened, identifying FH mutations in 1%. High acceptance rates among parents highlight feasibility. Vroni's approach, including reverse cascade screening for relatives, paves the way for integrating FH detection into routine care, advancing cardiovascular prevention.
Keywords: Familial hypercholesterolemia; LDL-C; Vroni study; genetic testing; screening.
© 2025. Springer Medizin Verlag GmbH, ein Teil von Springer Nature.
Conflict of interest statement
Interessenkonflikt. V. Sanin: Honorare für Vorträge von Amgen, Daiichi Sankyio, Novartis und Sanofi.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
